Abstract
Two research questions are addressed in this article. First, does technological competence enhance firm performance. Second, does competitor imitation of firm knowledge hurt performance. The relationships between technological competence, imitability and performance are basic premises in the resource-based view, yet there has been little empirical testing of them. Measures of technological competence and imitability are developed. These variables, together with measures of marketing and regulatory competence, are tested for their impact on firm performance in the pharmaceutical industry. Imitability has a negative and significant impact on accounting and market-based performance measures. Contrary to expectations, technological competence is inversely related to market-based performance measures and positively related to accounting measures. Research and managerial implications for the findings are discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
